July 9th 2025
Older patients with small cell lung cancer and significant weight loss were more likely to experience dose interruptions than patients with cachexia.
The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation
Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care
FDA Approves Olaparib for Breast Cancer With a BRCA Gene Mutation
Dr Mark Fendrick on Indication-Based Drug Pricing in Cancer Care